|
Dr. Windsor joined ETI in the spring of 2004 and currently serves as Managing Director and Senior Vice President of Portfolio Management. During his time at ETI, Dr. Windsor has served as Managing Director for five of ETI�s portfolio companies. He is also part of ETI�s Strategic Planning Group, which assesses new technology opportunities and oversees formation and implementation of portfolio company strategy. He holds a Ph.D. in molecular biology from the University of Texas at Austin, and his graduate work on cell transport modulation in the laboratory of Professor Alan Lloyd helped lead to the development of licensed technology. Prior to joining ETI, Dr. Windsor served as founder and Vice President of Research and Development for Texagen, Inc., a startup biotech company. Dr. Windsor is a co-inventor on 11 patents. | 